T-type calcium channels regulate neuronal excitability and are important contributors
of pain processing. CaV3.2 channels are the major isoform expressed in nonpeptidergic
and peptidergic nociceptive neurons and are emerging as promising targets for pain
treatment. Numerous studies have shown that CaV3.2 expression and/or activity are
significantly increased in spinal dorsal horn and in dorsal root ganglia neurons in
different inflammatory and neuropathic pain models. Pharmacological campaigns to inhibit
the functional expression of CaV3.2 for treatment of pain have focused on the development
of direct channel blockers, but none have produced lead candidates. Targeting the
proteins that regulate the trafficking or transcription, and the ones that modify
the channels via post-translational modifications are alternative means to regulate
expression and function of CaV3.2 channels and hence to develop new drugs to control
pain. Here we synthesize data supporting a role for CaV3.2 in numerous pain modalities
and then discuss emerging opportunities for the indirect targeting of CaV3.2 channels.
Keywords
Abbreviations:
AP (action potentials), CaV3.2 (voltage-gated calcium channel subfamily CaV3.2), CCD (chronic compression of DRG), CCI (chronic constriction injury), Cdk5 (cyclin-dependent kinase 5), CFA (complete Freund's adjuvant), CIPN (chemotherapy induced peripheral neuropathy), CRMP2 (collapsin response mediator protein), DRG (dorsal root ganglion), Egr-1 (early growth response 1), IGF-1 (insulin-like growth factor 1), HMGB1 (high mobility group box 1), HVA (high voltage-activated), H2S (hydrogen sulfide), LTMR (low-threshold mechanoreceptor), LVA (low-voltage activated), N2O (nitrous oxide), PDN (Peripheral diabetic neuropathy), PMA (phorbol 12-myristate 13-acetate), PKCα (protein kinase Cα), pSNL (partial sciatic nerve ligation), RAGE (receptor for advanced glycation end-products), REST (repressor element 1-silencing transcription factor), SDH (spinal dorsal horn), SNI (spared nerve injury), SNL (spinal nerve ligation), STZ (Streptozotocin), SUMO (small ubiquitin-related modifier), TTX-R (tetrodotoxin-resistant Na+ currents), USP5 (ubiquitin-specific cysteine protease 5/ isopeptidase T), WW1 (WW Domain Containing E3 Ubiquitin Protein Ligase 1)To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Translational ResearchAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- A Ca(v)3.2/syntaxin-1A signaling complex controls T-type channel activity and low-threshold exocytosis.J Biolog Chem. 2012; 287: 2810-2818
- Specific contribution of human T-type calcium channel isotypes (alpha(1G), alpha(1H) and alpha(1I)) to neuronal excitability.J Physiol. 2002; 540: 3-14
- Cloning and expression of a novel member of the low voltage-activated T-type calcium channel family.J Neurosci. 1999; 19: 1912-1921
- Molecular characterization of a neuronal low-voltage-activated T-type calcium channel.Nature. 1998; 391: 896-900
- International Union of Pharmacology. XLVIII. Nomenclature and structure-function relationships of voltage-gated calcium channels.Pharmacol Rev. 2005; 57: 411-425
- Phosphorylation of the Cav3.2 T-type calcium channel directly regulates its gating properties.Proc Natl Acad Sci USA. 2015; 112: 13705-13710
- T-type voltage-gated calcium channels as targets for the development of novel pain therapies.Br J Pharmacol. 2011; 163: 484-495
- Selective T-type calcium channel block in thalamic neurons reveals channel redundancy and physiological impact of I(T)window.J Neurosci. 2010; 30: 99-109
- Contributions of T-type calcium channel isoforms to neuronal firing.Channels. 2010; 4: 475-482
- Functional expression of T-type Ca2+ channels in spinal motoneurons of the adult turtle.PLoS One. 2014; 9e108187
- Characterization of the gating brake in the I-II loop of CaV3 T-type calcium channels.Channels. 2010; 4: 453-458
- Cav3 T-type channels: regulators for gating, membrane expression, and cation selectivity.Pflugers Arch Eur J Physiol. 2014; 466: 645-660
- Comparison of the Ca2 + currents induced by expression of three cloned alpha1 subunits, alpha1G, alpha1H and alpha1I, of low-voltage-activated T-type Ca2 + channels.Eur J Neurosci. 1999; 11: 4171-4178
- Inhibition of T-type voltage-gated calcium channels by a new scorpion toxin.Nat Neurosci. 1998; 1: 668-674
- Two new scorpion toxins that target voltage-gated Ca2+ and Na+ channels.Biochem Biophys Res Commun. 2002; 299: 562-568
- Kurtoxin, a gating modifier of neuronal high- and low-threshold ca channels.J Neurosci. 2002; 22: 2023-2034
- Characterization of ethosuximide reduction of low-threshold calcium current in thalamic neurons.Ann Neurol. 1989; 25: 582-593
- Amiloride selectively blocks the low threshold (T) calcium channel.Science. 1988; 240: 213-215
- CRMP2-binding compound, edonerpic maleate, accelerates motor function recovery from brain damage.Science. 2018; 360: 50-57
- T-type Ca2+ channels and pharmacological blockade: potential pathophysiological relevance.Cardiovasc Drugs Ther. 1997; 11: 723-739
- Mibefradil inhibition of T-type calcium channels in cerebellar purkinje neurons.Mol Pharmacol. 1998; 54: 1080-1087
- Pharmacological properties of T-type Ca2+ current in adult rat sensory neurons: effects of anticonvulsant and anesthetic agents.J Neurophysiol. 1998; 79: 240-252
- In vitro pharmacologic profile of Ro 40-5967, a novel Ca2+ channel blocker with potent vasodilator but weak inotropic action.J Cardiovasc Pharmacol. 1989; 13: 754-759
- Selective inhibition of T-type Ca2+ channels by Ro 40-5967.Circ Res. 1994; 75: 144-148
- Safety of mibefradil, a new once-a-day, selective T-type calcium channel antagonist.Am J Cardiol. 1997; 80 (40C-6C)
- Anti-anginal and anti-ischemic effects of mibefradil, a new T-type calcium channel antagonist.Cardiology. 1998; 89: 23-32
- What lessons can be learnt from withdrawal of mibefradil from the market?.Lancet. 1998; 351: 1829-1830
- Nickel block of three cloned T-type calcium channels: low concentrations selectively block alpha1H.Biophys J. 1999; 77: 3034-3042
- Molecular mechanisms of subtype-specific inhibition of neuronal T-type calcium channels by ascorbate.J Neurosci. 2007; 27: 12577-12583
- Reducing agents sensitize C-type nociceptors by relieving high-affinity zinc inhibition of T-type calcium channels.J Neurosci. 2007; 27: 8250-8260
- Ca(v)3.2 channel is a molecular substrate for inhibition of T-type calcium currents in rat sensory neurons by nitrous oxide.Mol Pharmacol. 2001; 60: 603-610
- 5beta-reduced neuroactive steroids are novel voltage-dependent blockers of T-type Ca2+ channels in rat sensory neurons in vitro and potent peripheral analgesics in vivo.Mol Pharmacol. 2004; 66: 1223-1235
- TTA-P2 is a potent and selective blocker of T-type calcium channels in rat sensory neurons and a novel antinociceptive agent.Mol Pharmacol. 2011; 80: 900-910
- In vitro characterization of T-type calcium channel antagonist TTA-A2 and in vivo effects on arousal in mice.J Pharmacol Exp Therapeut. 2010; 335: 409-417
- Z944: a first in class T-type calcium channel modulator for the treatment of pain.J Peripheral Nerv Syst: JPNS. 2014; 19: S11-S12
- Contribution of T-type calcium channels to spinal cord injury-induced hyperexcitability of nociceptors.J Neurosci. 2020; 40: 7229-7240
- Selective inhibition of Ca(V)3.2 channels reverses hyperexcitability of peripheral nociceptors and alleviates postsurgical pain.Sci Signal. 2018; 11: eaao4425https://doi.org/10.1126/scisignal.aao4425
- The endogenous redox agent L-cysteine induces T-type Ca2+ channel-dependent sensitization of a novel subpopulation of rat peripheral nociceptors.J Neurosci. 2005; 25: 8766-8775
- Expression and regulation of Cav3.2 T-type calcium channels during inflammatory hyperalgesia in mouse dorsal root ganglion neurons.PLoS One. 2015; 10e0127572
- Differential distribution of three members of a gene family encoding low voltage-activated (T-type) calcium channels.J Neurosci. 1999; 19: 1895-1911
- Presynaptic Cav3.2 channels regulate excitatory neurotransmission in nociceptive dorsal horn neurons.J Neurosci. 2012; 32: 9374-9382
- The low-threshold calcium channel Cav3.2 determines low-threshold mechanoreceptor function.Cell Rep. 2015; 10: 370-382
- Silencing of the Cav3.2 T-type calcium channel gene in sensory neurons demonstrates its major role in nociception.The EMBO J. 2005; 24: 315-324
- The roles of T-type calcium channel in the development of neuropathic pain following chronic compression of rat dorsal root ganglia.Pharmacology. 2010; 85: 295-300
- Upregulation of the T-type calcium current in small rat sensory neurons after chronic constrictive injury of the sciatic nerve.J Neurophysiol. 2008; 99: 3151-3156
- Chronic intrathecal infusion of mibefradil, ethosuximide and nickel attenuates nerve ligation-induced pain in rats.Br J Anaesth. 2015; 115: 105-111
- Chronic intrathecal infusion of T-type calcium channel blockers attenuates CaV3.2 upregulation in nerve-ligated rats.Acta anaesthesiologica Taiwanica. 2016; 54: 81-87
- Cdk5-dependent phosphorylation of CaV3.2 T-type channels: possible role in nerve ligation-induced neuropathic allodynia and the compound action potential in primary afferent C fibers.J Neurosci. 2020; 40: 283-296
- Nerve injury elevates functional Cav3.2 channels in superficial spinal dorsal horn.Mol Pain. 2019; 15 (1744806919836569)
- Upregulation of Ca(v)3.2 T-type calcium channels targeted by endogenous hydrogen sulfide contributes to maintenance of neuropathic pain.Pain. 2010; 150: 183-191
- Increased expression of CaV3.2 T-type calcium channels in damaged DRG neurons contributes to neuropathic pain in rats with spared nerve injury.Mol Pain. 2018; 141744806918765808
- Upregulation of T-type Ca2+ channels in primary sensory neurons in spinal nerve injury.Spine (Phila Pa 1976). 2013; 38: 463-470
- Dorsal root ganglion neurons become hyperexcitable and increase expression of voltage-gated T-type calcium channels (Cav3.2) in paclitaxel-induced peripheral neuropathy.Pain. 2017; 158: 417-429
- In vivo silencing of the Ca(V)3.2 T-type calcium channels in sensory neurons alleviates hyperalgesia in rats with streptozocin-induced diabetic neuropathy.Pain. 2009; 145: 184-195
- Cell-specific alterations of T-type calcium current in painful diabetic neuropathy enhance excitability of sensory neurons.J Neurosci. 2007; 27: 3305-3316
- Colocalization of insulin-like growth factor-1 receptor and T type Cav3.2 channel in dorsal root ganglia in chronic inflammatory pain mouse model.Neuroreport. 2016; 27: 737-743
- T-type calcium channels contribute to colonic hypersensitivity in a rat model of irritable bowel syndrome.Proc Natl Acad Sci USA. 2011; 108: 11268-11273
- Zinc deficiency promotes cystitis-related bladder pain by enhancing function and expression of Cav3.2 in mice.Toxicology. 2018; 393: 102-112
- Enhanced T-type calcium channel 3.2 activity in sensory neurons contributes to neuropathic-like pain of monosodium iodoacetate-induced knee osteoarthritis.Mol Pain. 2020; 16 (1744806920963807)
- Accumulation of Cav3.2 T-type calcium channels in the uninjured sural nerve contributes to neuropathic pain in rats with spared nerve injury.Front Mol Neurosci. 2018; 11: 24
- Upregulation of Cav3.2 T-type calcium channels in adjacent intact L4 dorsal root ganglion neurons in neuropathic pain rats with L5 spinal nerve ligation.Neurosci Res. 2019; 142: 30-37
- A role for uninjured afferents in neuropathic pain.Sheng li xue bao: [Acta physiologica Sinica]. 2008; 60: 605-609
- Ca(v)3.2 overexpression in L4 dorsal root ganglion neurons after L5 spinal nerve cutting involves Egr-1, USP5 and HMGB1 in rats: An emerging signaling pathway for neuropathic pain.Eur J Pharmacol. 2020; 173587
- The deubiquitinating enzyme USP5 modulates neuropathic and inflammatory pain by enhancing Cav3.2 channel activity.Neuron. 2014; 83: 1144-1158
- Small organic molecule disruptors of Cav3.2 - USP5 interactions reverse inflammatory and neuropathic pain.Mol Pain. 2015; 11: 12
- A cell-permeant peptide corresponding to the cUBP domain of USP5 reverses inflammatory and neuropathic pain.Mol Pain. 2016; : 12
- Prevention and treatment of chemotherapy-induced peripheral neuropathy. American journal of health-system pharmacy.AJHP. 2014; 71: 19-25
- Pathogenesis of paclitaxel-induced peripheral neuropathy: A current review of in vitro and in vivo findings using rodent and human model systems.Exp Neurol. 2020; 324113121
- Low-voltage-activated Ca2+ currents are generated by members of the CavT subunit family (alpha1G/H) in rat primary sensory neurons.J Neurosci. 1998; 18: 8605-8613
- A modulator of the low-voltage-activated T-type calcium channel that reverses HIV glycoprotein 120-, paclitaxel-, and spinal nerve ligation-induced peripheral neuropathies.Pain. 2020; 161: 2551-2570
- Betulinic acid, derived from the desert lavender Hyptis emoryi, attenuates paclitaxel-, HIV-, and nerve injury-associated peripheral sensory neuropathy via block of N- and T-type calcium channels.Pain. 2019; 160: 117-135
- The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population-based cohort: the Rochester Diabetic Neuropathy Study.Neurology. 1993; 43: 817-824
- Painful diabetic neuropathy: epidemiology, natural history, early diagnosis, and treatment options.Pain Med. 2008; 9: 660-674
- Upregulation of T-type Ca2+ channels in long-term diabetes determines increased excitability of a specific type of capsaicin-insensitive DRG neurons.Mol Pain. 2015; 11: 29
- Specific functioning of Cav3.2 T-type calcium and TRPV1 channels under different types of STZ-diabetic neuropathy.Biochimica et biophysica acta. 2013; 1832: 636-649
- Voltage-dependent calcium currents are enhanced in dorsal root ganglion neurones from the Bio Bred/Worchester diabetic rat.J Physiol. 1995; 486: 313-322
- Reversal of neuropathic pain in diabetes by targeting glycosylation of Ca(V)3.2 T-type calcium channels.Diabetes. 2013; 62: 3828-3838
- Surface expression and function of Cav3.2 T-type calcium channels are controlled by asparagine-linked glycosylation.Pflugers Arch Eur J Physiol. 2013; 465: 1159-1170
- Selective T-type calcium channel blockade alleviates hyperalgesia in ob/ob mice.Diabetes. 2009; 58: 2656-2665
- Hyperhomocysteinemia and neurologic disorders: a review.J Clin Neurol. 2014; 10: 281-288
- A potential role for T-type calcium channels in homocysteinemia-induced peripheral neuropathy.Pain. 2019; 160: 2798-2810
- Attenuated pain responses in mice lacking Ca(V)3.2 T-type channels.Genes Brain Behav. 2007; 6: 425-431
- Inhibition of Cav 3.2 calcium channels: a new target for colonic hypersensitivity associated with low-grade inflammation.Br J Pharmacol. 2019; 176: 950-963
- Chelating luminal zinc mimics hydrogen sulfide-evoked colonic pain in mice: possible involvement of T-type calcium channels.Neuroscience. 2011; 181: 257-264
- Involvement of the endogenous hydrogen sulfide/Ca(v) 3.2 T-type Ca2+ channel pathway in cystitis-related bladder pain in mice.Br J Pharmacol. 2012; 167: 917-928
- Peripheral pain is enhanced by insulin-like growth factor 1 through a G protein-mediated stimulation of T-type calcium channels.Sci Signal. 2014; 7: ra94
- Structural determinants of the high affinity extracellular zinc binding site on Cav3.2 T-type calcium channels.J Biolog Chem. 2010; 285: 3271-3281
- A molecular determinant of nickel inhibition in Cav3.2 T-type calcium channels.J Biolog Chem. 2006; 281: 4823-4830
- Transcriptional regulation of T-type calcium channel CaV3.2: bi-directionality by early growth response 1 (Egr1) and repressor element 1 (RE-1) protein-silencing transcription factor (REST).J Biol Chem. 2012; 287: 15489-15501
- SUMOylation regulates USP5-Cav3.2 calcium channel interactions.Mol Brain. 2019; 12: 73
- Identification of interleukin-1 beta as a key mediator in the upregulation of Cav3.2-USP5 interactions in the pain pathway.Mol Pain. 2017; 131744806917724698
- Disrupting USP5/Cav3.2 interactions protects female mice from mechanical hypersensitivity during peripheral inflammation.Mol Brain. 2018; 11: 60
- Regulation of neuronal T-type calcium channels.Trends Pharmacol Sci. 2009; 30: 32-40
- Modulation of low-voltage-activated T-type Ca(2)(+) channels.Biochim Biophys Acta. 2013; 1828: 1550-1559
- Glycosylation of voltage-gated calcium channels in health and disease.Biochim Biophys Acta Biomembr. 2017; 1859: 662-668
- Glycosylation increases potassium channel stability and surface expression in mammalian cells.J Biolog Chem. 2001; 276: 34028-34034
- Identification of novel N-glycosylation sites at noncanonical protein consensus motifs.J Proteome Res. 2016; 15: 2087-2101
- N-glycosylation at non-canonical Asn-X-Cys sequence of an insect recombinant cathepsin B-like counter-defense protein.Comp Biochem Physiol B Biochem Mol Biol. 2010; 156: 40-47
- Functional identification of potential non-canonical N-glycosylation sites within Cav3.2 T-type calcium channels.Mol Brain. 2020; 13: 149
Article info
Publication history
Published online: January 07, 2021
Accepted:
January 4,
2021
Received in revised form:
December 31,
2020
Received:
December 8,
2020
Identification
Copyright
© 2021 Elsevier Inc. All rights reserved.
